Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New Na+/H+ exchange inhibitor protects against lung I/R injury in canine model

Nov. 24, 2000

Preclinical evidence points to utility of FR-167653 in organ transplantation

Nov. 24, 2000

Xanthine-based inhibitors of IL-12 signaling patented by Cell Therapeutics

Nov. 20, 2000

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Nov. 20, 2000

Licensing opportunity from NIH: chimeric viruses as vaccine candidates

Nov. 20, 2000

CytRx and Merck enter TranzFect agreement

Nov. 16, 2000

Licensing opportunity from NIH: subunit vaccine for viral diseases

Nov. 16, 2000

FK-3311 reduces ischemia/reperfusion injury to the lung in rat model

Nov. 15, 2000

Galenica and U.S. Navy to evaluate malaria vaccine adjuvant

Nov. 15, 2000

Encouraging preclinical data reported for BioSante's CAP vaccine adjuvant

Nov. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...